跳至主要内容
临床试验/CTRI/2021/05/033742
CTRI/2021/05/033742招募中未知

A Retrospective study of Comparing outcomes of Moderate and severe COVID-19 Pneumonia in patients treated with guideline based remdesivir regimen and non-remdesivir regimen� RESCUER study - RESCUER

Government of Tamilnadu0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Age ââ?°Â¥12 years with Confirmed COVID-19. (Laboratory (RT-PCR) ââ?¬â?? Positive)
  • Moderate COVID pneumonia:
  • Moderate Pneumonia (frequent fever, cough) with no obvious hypoxemia, chest CT with lesions.
  • Severe COVID pneumonia:
  • Severe Pneumonia with hypoxemia (SpO2 < 92%).
  • Patients received Remdesivir (Case) and also not received it (Control group).

排除标准

  • Mild infection (without CT lesions)
  • Critical pneumonias (CT involvement > 75%).
  • Patients with moderate and Severe pneumonia but died within 3 days of hospital admission.
  • Patient who received Tocilizumab (critical pts)
  • Severe liver disease (AST > 5 times upper limit)
  • Patients with severe renal impairment (estimated GFR ââ?°Â¤30 mL/min/1.73 m2) or receiving continuous Dialysis
  • Pregnant or breastfeeding mothers.
  • Patient transferred to another hospital within 72 hours.
  • Cases with inadequate datas.

研究者

相似试验